ESMO Congress 2025

Welcome to the Elsevier exhibit landing page for ESMO 2025! We are thrilled to announce our participation at this year's conference and invite you to explore our latest offerings at booth P2012. As a leading publisher in the field of oncology, we are committed to sharing the latest research and insights to help advance cancer research, treatment, and care. On this page, you’ll find information about our journals, our freely accessible breast cancer article collection, the Elsevier Oncology Journal Network, and the ESMO journal portfolio.

We look forward to seeing you at booth P2012 at the conference!

Annals of Oncology

• Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline

• Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials

Cancer Letters

• Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics

Cancer Pathogenesis and Therapy

• Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells

• Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population

Cancer Treatment and Research Communications

• Cardiotoxicity in breast cancer treatment: Causes and mitigation

Cancer Treatment Reviews

• Ovarian escape in premenopausal breast cancer: Challenges and strategies for optimizing hormone suppression

• Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies

Clinical Breast Cancer

• The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)

• Metaplastic Breast Cancer: Current Understanding and Future Directions

Clinical Oncology

• Ten-Year Outcomes of Stereotactic Body Radiotherapy for Oligometastatic Breast Cancer: Does Synchronous Oligometastatic Breast Cancer Benefit?

Clinical Surgical Oncology

• Outpatient revisits associated with three sentinel lymph node detection techniques for breast cancer: A propensity score weighted analysis

• Confirmation of the importance of lymphatic leakage in the formation of axillary fluid collections after lymph node dissection for breast cancer

Current Problems in Cancer: Case Reports

• ML: Early Breast Cancer Diagnosis

Current Problems in Cancer

• Imaging of breast cancer–beyond the basics

European Journal of Cancer

• Comparison of hypofractionation and conventional fractionation in postmastectomy radiotherapy after immediate breast reconstruction: A systematic review and meta-analysis of complications

• Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial

ESMO Open

• Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study

• Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort study

ESMO Rare Cancers

• Molecular pathobiology of breast fibroepithelial tumours

ESMO Real World Data and Digital Oncology

• Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer

• Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis

International Journal of Particle Therapy

• Cardiac Substructure Dose Reduction and Toxicity Risk Assessment: IMPT Versus IMRT for Breast Cancer

• NTCP-Based Prediction of Lung Sparing With IMPT in BC Patients and Implication of Patient Selection

• Dose Constraints in Carbon-Ion Radiation Therapy to Minimize the Risk of Pectoral Myositis

International Journal of Radiation Oncology, Biology, Physics

• Beyond Technology: The Impact of Personal Physics Consultation on Patient Anxiety in Breast Cancer Radiotherapy

• HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): Acute toxicity results.

Journal of the National Cancer Center

• Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study

• Guidelines for diagnosis and treatment of advanced breast cancer in China (2022 edition)

Magnetic Resonance Imaging

• Prediction of HER-2 expression status in breast cancer based on multi-parameter MRI intratumoral and peritumoral radiomics

• Study on predicting breast cancer Ki-67 expression using a combination of radiomics and deep learning based on multiparametric MRI

Neoplasia

• Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients

Oral Oncology

• Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer

Practical Radiation Oncology

• Favorable Rates of Excellent or Good Cosmetic Outcomes in Patients Treated With Carefully Planned Accelerated Partial Breast Irradiation Delivered Twice Daily or Once Every Other Day

• "The Efficacy and Toxicity of Hypofractionated Regional Nodal Irradiation in Breast Cancer Patients"

Radiation Medicine and Protection

• A review of therapeutic agents for breast cancer with potentially radiosensitizing properties

Radiotherapy and Oncology

• What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?

• Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial

Seminars in Oncology

• Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment

• A 3-miRNA signature for noninvasive breast cancer detection

Seminars in Ultrasound, CT, and MRI

• The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy

Surgical Oncology

• Breast Cancer-Related Lymphedema: A Critical Review on Recent Progress

• The accuracy of MRI in detecting pathological complete response following neoadjuvant chemotherapy in different breast cancer subtypes

The Breast

• Physicians’ knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 survey

• Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Translational Oncology

• Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection

Elsevier’s Oncology Journal Network

Publish Open Access in Elsevier Journals

Open access is vital to a collaborative, inclusive and transparent world of research where quality knowledge can be shared and built upon. Every day, we work to bring more insight into closer reach for the research community and the public. We offer a wide choice and flexibility for every researcher and institution around the world that wants to publish open access, without ever compromising on research quality, integrity and value.